Desloratadine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FVF865388R, chemically known as 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)- but generally known as desloratadine, which bears US NIH Compound Identifier 124087. European Medicines Agency schedules Desloratadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01596MIG. The term DESLORATADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules desloratadine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule desloratadine under HS 29333999 and SITC 51574. As of Q4 2014, DESLORATADINE remains the US FDA Preferred Term for this commodity. Desloratadine bears US NLM identifiers UMLS ID C0908935 and NCI Concept Code C47474. SMILES: CLC1CC2C(/C(=C3/CCNCC3)C3NCCCC3CC2)CC1.